Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Syneos Health Inc SYNH

Syneos Health, Inc. is a biopharmaceutical solutions company that utilizes outsourced clinical drug development and commercialization services. The Company operates through two business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span... see more

NDAQ:SYNH - Post Discussion

Syneos Health Inc > $SYNH $ HUGE unable to recruit scam
View:
Post by DavidRosenberg on Jul 18, 2023 7:57am

$SYNH $ HUGE unable to recruit scam

Incompetence by Syneos health

 FSD Pharma is looking  to get in touch with companies who are in a similar situation with Syneos health seems like these incompetent "contract research organizations" scam small biotechs with no patients tested yet tout they are professional 

they couldn't recruit any patients yet kept billing fsd Pharma by the way im a fsd Pharma investor and I'm pissed at this that's why I'm posting this for all to see !!!

Syneos was unable to recruit patients yet kept billing fsd Pharma !!!! What's up with that 


https://financialpost.com/pmn/business-wire-news-releases-pmn/arbitration-panel-finds-that-syneos-health-nasdaq-synh-failed-to-use-commercially-reasonable-efforts-in-conducting-its-trial-for-fsd-201
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities